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1.  Overview 
 
 
1.1  What is the ethical matrix? 
 
The ethical matrix is a conceptual tool designed to help decision-makers (as 
individuals or working in groups) reach sound judgements or decisions about the 
ethical acceptability and/or optimal regulatory controls for existing or 
prospective technologies in the field of food and agriculture.  
 The ethical matrix applies a number of prima facie principles to a set of 
selected interest groups. The standard principles are: respect for wellbeing, 
autonomy and fairness, and together they form the columns of the ethical matrix. 
The rows consist of the 'interest groups' (i.e. affected parties) that are relevant to 
the issue in question. These might include different groups of people, such as 
consumers and food producers, but also non-humans, such as farm animals. The 
arrangement of principles and interest groups in a table, forming the ethical 
matrix, facilitates easy cross-referencing in deliberation and subsequent 
reflection on an issue. 
 The ethical matrix was initially designed to facilitate ethical deliberation by 
those with particular knowledge and/or interest in novel biotechnologies, but 
who may have little or no formal training in academic ethical theory or have only 
limited experience in applying such theory to concrete issues. The aim of the 
ethical matrix is to help users identify ethical issues raised by the use of novel 
technologies and to arrive at intellectually defensible decisions. However, the 
ethical matrix does not prescribe any particular decisions. 
 
 
1.2  By whom and when can the ethical matrix be used? 
 
The ethical matrix may be used by a number of groups or individuals in order to 
structure ethical deliberation, for example on the use of new biotechnologies. A 
number of organisations can apply the tool, including: 
- governmental advisory committees and/or ad hoc working parties; 
- ethics committees at various levels; 
- non-governmental organisations; 
- participants in exercises in public deliberation; 
- commercial companies. 
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The ethical matrix has also been used by individuals to examine bioethical issues 
in academic publications, in courses at secondary schools and universities, and in 
a web-based educational program. The ethical matrix can be used:  
- at a strategic level to review ethical dimensions; 
- to review the specific ethical impacts of individual technologies (e.g. for a 
patent or licence application). 
 
 
1.3  What are the expected outcomes of exercises using the ethical 
matrix? 
 
Use of the ethical matrix may be expected to result in one or more of the 
following outcomes: 
- raise awareness of a wide range of ethical issues; 
- encourage ethical reflection; 
- provide a common basis for ethical decision-making; 
- identify areas of agreement between individuals who might nevertheless 
differ in their overall judgements; 
- clarify the basis of disagreements; 
- make explicit the reasoning that underpins any ethical decisions. 
 
 
1.4  What the ethical matrix cannot do 
 
Although the ethical matrix aims to provide a structure for ethical deliberation, it 
would be wrong to assume that its use could ever enable a committee to arrive at 
a definitive judgement without applying sound independent ethical reflection and 
judgement. For the process to be effective, decision-makers must reach a 
measure of agreement on the interpretation of the principles. Different 
interpretations of the weights assigned to each of the principles by different 
people preclude a definitive ethical judgement. Thus, it is not possible to 
automatically arrive at a unique or prescribed course of action from the use of 
the ethical matrix.  
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2.  Background theory 
 
 
The ethical matrix was introduced by Mepham (Centre for Applied Bioethics, 
University of Nottingham) in 1994 and has been further developed since then. It 
has been used to review a number of emerging biotechnologies, including: 
bovine somatotrophin, GM salmon, the use of transgenic animals in 
experimentation, Xenotransplantation, functional foods and GM crops. Over the 
last ten years the method has also been used by various European Groups (for 
example in The Netherlands, Germany, UK and Norway) and by a range of 
committees, from government advisory groups to NGOs. In addition it has been 
used in teaching and training contexts.  
 Methodologically, the ethical matrix is a development of the principles 
encompassed by the common morality, i.e. the ethical code shared by most 
members of a society in the form of unreflective common sense and tradition. 
However, because the common morality may only amount to the 'lowest 
common denominator,' it is likely that real progress in addressing ethical issues 
will only be made by conscientious, informed dialogue which goes well beyond 
'unreflective common sense.'  
 The aim of the ethical matrix is to select principles that collectively are 
representative of the two major traditions of ethical theory and thinking of 
western societies. This means that these traditions, namely, consequentialism 
and deontology, should be represented by adequate principles.  
 This section sets out the core elements of the theoretical background of the 
ethical matrix method. Further information on the development of the method 
and more extensive information on the ethical theories discussed can be found in 
Section 2.6. 
 
 
2.1  What are the essential features of the ethical matrix? 
 
There are several ways in which the ethical matrix can be applied to assist 
decision-making, but all uses share some important common features. In all 
cases, the ethical matrix offers:  
- a good starting point for ethical deliberation (i.e., a process which entails 
the careful consideration and discussion of the ethical implications of an 
issue) which encompasses both:  
 a.  different perspectives (e.g. stakeholders or affected parties), from 
which the impact of a proposed novel technology can be assessed; 
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 b. different concerns, (i.e. ethical principles) according to which the 
impact of a proposed technology may be differentiated and analysed. 
- however, the possibility of conflicting outcomes in applying the principles 
to specific cases suggests that it is best to consider the principles as prima 
facie in nature. This implies that, typically, some principles will need to be 
assigned more importance, or weight, than others. That is to say, when 
examining the specifics of a case, a particular principle, although given due 
consideration in the analysis, may be overridden by another principle that is 
deemed more important; 
- the weight assigned to particular principles in specific cases usually differs 
between people using the ethical matrix, and to some extent this is because 
ethical deliberation entails an appeal to several forms of evidence. 
'Evidence' is defined here as 'anything that provides material or information 
on which a conclusion or proof is based'. Such forms of evidence include, 
for example: 
 a. scientific and economic data; 
 b. assessments of the consequences of risk and uncertainty (e.g.  
  reflected in the different ways people apply the Precautionary  
  Principle); 
 c. assessments of the intrinsic value of different forms of life   
  (which may reflect peoples' differing world views); 
 d. tacit, folk or practical knowledge. 
- qualitative or quantitative assessments of impacts recorded in the different 
cells of the ethical matrix (ethical analysis) provide a road map of salient 
ethical concerns, the different weightings of which underpin the various 
ethical judgements made. 
 
 
2.2  How is ethical theory represented in the ethical matrix? 
 
The ethical matrix is based on the concept of prima facie principles (i.e. rules of 
action that are 'valid at first appearance'), as described by the American medical 
bioethicists Beauchamp and Childress. Prima facie principles differ from other 
principles by allowing a stronger case to overrule a weaker one in particular 
circumstances. This facilitates ethical decision-making - because following the 
principles rigidly might easily end up in a deadlock, or appear to endorse 
conflicting courses of action. The standard version of the ethical matrix operates 
with the three prima facie principles of 'respect for wellbeing, autonomy and 
fairness', which together form the columns of the ethical matrix (for definitions 
see Box 1).  
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Respect for: 
 
o Wellbeing is considered to be the best way of representing 
utilitarian concerns ('maximising the good') 
o Autonomy represents deontological concerns (treating others as 
'ends in themselves')  
o Fairness represents respect for justice, an interpretation 
advocated by the philosopher Rawls 
 Box 1 Principles used in the ethical matrix 
 
The rows consist of the 'interest groups' that are relevant to the issue in question. 
These might include different groups of people, such as consumers and food 
producers, but also non-humans, such as farm animals or wildlife (also 
designated 'the biota') This is because the purpose of the ethical matrix is to help 
consider each interest group in relation to each of the three principles.  
 Which interest groups are included in the ethical matrix depends partly on 
the issue at hand. A critical factor is that 'ethical standing' is claimed for all 
interest groups specified. In other words, they are subjects of ethical 
consideration in their own right, and not just means to others' ends. Furthermore, 
the way they are affected by a novel technology should differ systematically 
from each other. Thus, even though all producers are also consumers, in respect 
to a given technology, they will usually be affected differently. 
 Given these practical constraints, it has usually been found possible to limit 
the ethical matrix to four interest groups. A generic version of the ethical matrix 
(see Figure 1) can be adapted to address a range of different issues in food and 
agriculture. Each cell then specifies the main criterion that would be met if a 
particular principle (e.g. fairness) were respected for a particular interest group 
(e.g. consumers).  
However in order to be of value in specific cases the rather abstract 
principles used in the generic ethical matrix (Figure 1) often need to be specified 
in ways that more accurately reflect the particular issue under consideration. For 
example, Figure 2 illustrates a form of ethical matrix used in analysing the 
ethical impacts of using the commercially produced hormonal preparation 
(bovine somatotrophin, bST) to increase the milk yields of dairy cattle. This 
example is explored more fully in Section 5.1. 
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Respect for: Wellbeing Autonomy Fairness 
Producers 
 
Satisfactory income 
and working 
conditions 
Managerial 
freedom 
 
Fair trade laws 
Consumers Safety and 
acceptability 
Choice Affordability 
 
Treated 
organisms 
Welfare Behavioural 
freedom 
Intrinsic value 
Biota Conservation Biodiversity Sustainability 
 
 Figure 1 A generic ethical matrix 
 
Respect for:  Wellbeing Autonomy Fairness 
Dairy 
Farmers 
Satisfactory 
income and 
working 
conditions 
Managerial freedom 
of action 
 
Fair trade laws 
and practices 
 
Consumers Food safety and 
acceptability; 
Quality of life 
Democratic, 
informed choice e.g. 
of food 
Availability of 
affordable food 
 
 
Dairy cows Animal welfare 
 
Behavioural 
freedom 
Intrinsic value 
 
Biota Conservation Biodiversity Sustainability 
 Figure 2 An ethical matrix used in the ethical analysis of bST use in dairy cattle 
(Mepham, 2005) 
 
As noted above, different groups, to address different issues have used the 
ethical matrix approach in different ways and its versatility might be considered 
one of its particular merits. For example, Figure 3 shows an ethical matrix that 
was used to examine issues faced by the Norwegian fishing industry, in which 
the principles of respect for 'dignity' and 'justice' replace those for 'autonomy' 
and 'fairness' in Figures 1 and 2. The number of interest groups in this case is 
increased from four to seven (to include, e.g. 'the fishing industry' and 'future 
generations') and the principles are specified much more fully than in Figure 1. 
Such amendments to the generic ethical matrix were introduced as a result of 
discussions with representatives of the various stakeholder groups involved, e.g. 
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fishermen and consumers. The use of the ethical matrix in public participatory 
exercises is considered in more detail below (see Section 3.4). 
 
Respect for: Wellbeing Dignity Justice 
Fishermen 
 
Safe and secure 
workplace and income, 
as well as stable social 
situation 
Right to control of 
their work situation 
and respect for their 
occupation 
Equal right to 
professional practice 
for different categories 
of fishermen  
Fishing 
industry 
Stable deliveries from 
the fisheries; a part of 
the welfare goods 
obtained in the value 
chain 
Acknowledgement of 
their place in the 
value chain: being 
heard in negotiations.  
 
 
Equal terms for this 
industry as for other 
marine occupations 
Other users 
of the sea and 
coast 
Access to welfare goods 
directed at marine 
activities as other users 
Respect for their 
needs and their use of 
the coast and sea 
Equal access to the 
resources 
The society as 
a whole 
 
Income from marine 
activities 
Freedom to manage 
resources for the best 
of society as a whole 
Equal living conditions 
for urban and rural 
societies 
Consumers Guarantees for healthy 
food in adequate 
amounts 
Opportunities for the 
consumer to chose 
and influence the 
production of food 
products 
Fish products of good 
quality available for 
different consumer 
groups 
Future 
generations 
No activities that 
threaten their health or 
living conditions 
Knowing that earlier 
generations acted 
with respect for their 
welfare 
The conservation of 
marine environment 
and resources so that 
future generations will 
have the same 
opportunities we have 
The 
biosphere 
That fish and other 
animals are not exposed 
to unnecessary pain 
 
Harm and abuse of 
nature as limited as 
possible 
 
The diffusion to a 
viable level of 
environmental burdens 
over a variety of 
ecosystems 
Figure 3 A customised version of the ethical matrix designed to assess the future of the 
Norwegian fishing industry (Kaiser and Forsberg, 2001) 
 
 
2.3  Ethical analysis and evaluation 
 
Ethical analysis using the ethical matrix usually entails comparing two 
situations. Often these are, firstly, the current situation (the status quo) and, 
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secondly, the situation that is expected to result from the introduction of a new 
biotechnology. For example, growing a herbicide-tolerant GM food crop might 
be expected to increase yields, reduce susceptibility to biotic stresses, increase 
producers' profits and reduce prices of food products in the shops. But these 
impacts (commonly perceived as positive) might, to a degree, be offset by 
negative effects, such as reduced biodiversity in the farmland environment, loss 
of farm jobs, reduced consumer choice and threats to the certified status of 
organic farmers. The ethical matrix serves, in the first instance, to provide a 
template for detailed discussion of these and other concerns. 
 A common way of using the ethical matrix is to 'score' the perceived 
impacts for each cell using a semi-quantitative scale, e.g. ranging from -2 to +2. 
For example, in the case of the prospective use of GM herbicide-tolerant crops, 
respect for farmers' profits might be modestly increased (i.e. the score = +1), 
whereas because of wider impacts on wildlife, biotic autonomy (specified as 
'biodiversity') might be decreased (score = -1). Insignificant impacts are recorded 
as '0.' It is important to stress that use of scoring does not imply that one can 
'calculate' a judgement by aggregating the scores entered for each cell. Not only 
are the scores very imprecise, being simply short-hand for 'very' (+2 and -2) and 
'quite' (+1 and -1), but scores in different cells are not of equal weight. 
Therefore, to aggregate the scores of the different cells in an ethical matrix 
would be a serious misuse of the ethical matrix.  
 Some users have employed a wider scale (+5 to -5) to provide added 
discrimination, but others rely on noting 'positive' and 'negative' impacts only, 
without using scores. In some uses of the ethical matrix, it merely serves to 
identify ethical issues, and no attempt is made to quantify assessments of the 
impacts on different principles. Even so, judgements made in such cases may 
benefit from the deliberative process and the recorded comments made during 
discussions and/or debates. 
 
2.3.1  Content of the cells 
 
The factors in each cell of the ethical matrix, which are relevant to performing an 
ethical analysis, can be considered as forms of evidence (see Section 2.1). But 
evidence seems to come in two major types that conform to the categories of 
'facts' and values'.  
 
Facts  
To perform an analysis of the GM crop, you would need to know, for example: 
- what increases in yield are obtained when the GM crop is grown, and the 
likely secondary effects on financial profits; 
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- whether any effects on the chemical nature of the crop have implications for 
consumer health; 
- whether biodiversity is affected, positively or negatively. 
 
Some people consider that because we often are dealing here with quantifiable 
'facts,' the answers to such questions should be straightforward. But the nature of 
the 'facts', i.e. whether they were obtained reliably, and whether they are relevant 
to the question at hand, are all matters over which there is sometimes 
considerable disagreement. Even the scientific theory considered to justify 
particular data examined may be questioned, and if the supplier of the data is 
thought to be biased (e.g. if a commercial company produced the key data 
supporting their own product, or if the data were produced by a pressure group 
known to be ideologically opposed to the product) neutral observers might 
suspect that the evidence was unreliable. Assessing evidence may thus entail 
examining different versions of the facts where there is controversy; and 
assessment of the trustworthiness of the evidence may be important. Any such 
qualifications need to be reflected in assessments of the evidence recorded in the 
cells.  
 
Values  
In other cases, values are more important than facts, and in contrast to factual 
data, consideration of these cells of the ethical matrix requires an individual 
judgement that is not only dependent on quantifiable consequences, but on the 
value attributed to them. For example, in the pursuit of national economic 
objectives by allowing the growing of GM crops, a value judgement is required 
on the extent to which it is acceptable to e.g. threaten the livelihoods of organic 
farmers, or to take unknown risks with human health if appropriate scientific 
evidence on food safety is unavailable. Someone, on the one hand, advocating 
radical free market economics and someone else, on the other hand, believing in 
a social market economy might well agree on some of these factual outcomes, 
but they would presumably differ in the weight they assign to them. The cells of 
the ethical matrix can record these outcomes as well as include the evaluative 
qualifications that follow.  
 
Possible asymmetries between positive and negative scores 
In theory, for any proposed action, any of the principles specified in the 
individual cells of the ethical matrix might either be respected (earning a positive 
score) or infringed (deserving a negative score). But positive and negative scores 
do not necessarily balance each other, even for a single specification. Thus, 
sometimes the duty 'not to harm' might be thought to be more compelling than 
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the duty to 'do good.' An illustrative example is use of a GM hormone (bST) to 
increase milk yields in cattle (see Section 5.1), when the duty not to harm the 
animals is often considered much more important than the duty to improve their 
lot. Just as different principles often carry different weights, so can positive and 
negative effects for a given principle. The underlying rationale for this is that in 
ethics actions and omissions are not automatically on a par.  
 
2.3.2  Ethical evaluation  
 
It would not be possible on the basis of the above form of analysis to directly 
deduce the ethical acceptability of any proposed technology, for two reasons. 
Firstly, as noted, different individuals may assign different weights to different 
principles and to the evidence. Consequently, the principal objective of the 
ethical matrix - to integrate and respect a variety of ethical concerns - cannot be 
reached by summing up scores. The next step in the process, ethical evaluation, 
involves subjectively weighing the different impacts, which allows you to reach 
an ethical judgement on the acceptability of the technology in question.  
 Secondly, the ethical matrix does not assess overall ethical acceptability 
because such a judgement would be dependent on available alternatives. When 
comparing the overall ethical acceptability of two situations, neither might be 
ethically acceptable by comparison with some third option. In other words, a 
system adjudged marginally more ethically acceptable than another according to 
the analysis might still fall far short of a system that has not been investigated. 
But performing an ethical evaluation may be considerably improved by going 
through this process. What you get out of the ethical matrix is totally dependent 
on what you put in. 
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3.  Users of the ethical matrix: user groups and 
objectives 
 
 
When considering whether to apply the ethical matrix, a user should consider a 
number of contextual and logistical issues. This section includes information on 
who should, when, and how, to apply the ethical matrix. General methods and 
user information are set out in the following sections, but further details on the 
use of the ethical matrix for specific case studies are given in the section on case 
studies (see Section 5). 
 
 
3.1  Different ways the ethical matrix can be used 
 
The ethical matrix may be used in several ways and by different groups of 
people, or even by individuals. So it is not surprising that the organizational 
requirements are likely to be quite different in different circumstances; and to be 
critically influenced by factors that are not directly related to the nature of the 
ethical matrix as an ethical tool. Such factors not only include financial and time 
limitations but also the degree to which participants in a group exercise are 
encouraged to set the agenda themselves rather than follow a prescribed 
procedure. With reference to the latter point, the different ways in which the 
ethical matrix may be used will be greatly influenced by whether its use 
conforms more to a 'top-down' approach than to a 'bottom-up' approach. 
 
3.1.1  Top-down approach 
 
In a top-down approach the specifications of the ethical matrix principles are 
largely set by the organizers, who have acknowledged expertise in facilitating 
bioethical deliberation, and play a prominent role in structuring the exercise.  
 
3.1.2  Bottom-up approach 
 
In a bottom-up approach the organizers provide less explicit guidance, and defer 
to the majority views of the (usually) inexpert participants in specifying the 
principles and conducting ethical deliberation.  
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3.1.3  Which one to choose 
 
Advantages of the top-down approach are that it provides a firm structure for 
debate, ensures that discussion is focused on the relevant issues and facilitates 
closure of the debate. However, to the extent that the organizers direct the 
proceedings the top-down approach may (appear to) be undemocratic, and it is 
vulnerable to intentional or unintentional abuse. The bottom-up approach has the 
advantage that it is more explicitly democratic (although it also depends 
critically on the organizers' advice) and can, in theory, respond more readily to 
grass-roots issues. However, the main risk of the bottom-up approach is that 
participants' misconceptions as to the purpose and methodology of the ethical 
matrix may distort the exercise and undermine its true objectives. At worst, if the 
participants fail to appreciate the importance of the method, the bottom-up 
approach might be (mis)used to justify a partisan viewpoint. Thus, both the top-
down approach and bottom-up approach carry some risks.  
 Despite these caveats, and provided that users are aware of them, 
adequately resourced exercises using the ethical matrix should facilitate 
attainment of all of the objectives listed in Section 1.3. However, in all uses of 
the ethical matrix it is necessary to appreciate that it is not just a procedural tool 
but also a substantive tool. That is to say, the ethical matrix can only be expected 
to prove of real value if users are prepared to engage conscientiously with the 
issues at a theoretical level, and not to assume that it merely involves 'ticking 
boxes.' Of its nature, the ethical matrix inevitably makes more demands on users 
than would, say, completing an opinion survey. 
 The next three sections (3.2 – 3.4) identify the principal features of the 
three main ways the ethical matrix can be used. More detailed guidance on 
organizational matters is provided in subsequent sections. 
 
 
3.2  Use of the ethical matrix by a small group (and by individuals)  
 
The major limiting factor here is the lack of diversity of viewpoints, but to a 
degree, especially with small groups, this deficiency might be offset by the 
concentrated effort and high level of interaction between the participants that can 
be brought to the deliberative process. For convenience, it is assumed here that a 
working party of six people is using the ethical matrix to formulate an ethical 
position on a new biotechnology. In such circumstances it is important to adhere 
to the guidelines outlined in Box 2.  
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a)Access to professional advice on ethical theory in deciding on the 
relevant interest groups to include in the ethical matrix and on the 
specifications of the principles to be used. The generic ethical matrix 
in Figure 1 provides a basis for most formulations, but particular 
cases may require different or additional interest groups and/or 
reformulation of the principles (e.g. as in Figure 2). 
b) Authoritative technical advice (e.g. scientific, economic and 
sociological) must be available, preferably from experts who can be 
interrogated e.g. to explore issues of uncertainty which may not be 
evident from printed publications. 
c) A willingness by members of the working party to 'put themselves 
in the shoes' of each interest group in turn in assessing the ethical 
impacts of the biotechnology. 
 Box 2 Guidelines for effective use of the ethical matrix 
 
If the working party is drawn from a cross section of society, the output of such 
deliberations is most likely to be a discussion document which identifies areas of 
agreement and disagreement and may serve as a stimulus for wider consultation. 
On the other hand, an NGO working party, with a particular ideological stance 
on biotechnology in general, might find in the ethical matrix a tool that 
effectively systematizes its position on the specific biotechnology in question. 
 
 
3.3  Use of the ethical matrix by a government commission/advisory 
body 
 
Typically, advisory committees experience fewer constraints than those 
identified in section 3.2, efforts having usually been made to select a 
membership representing a wide range of expertise and viewpoints. Moreover, 
such bodies are usually able to call on the highest level of technical advice 
available, and have easy access to legal and economic advice provided by 
government departments. They are usually supported by an efficient secretariat. 
 The guidelines summarized in Box 2 are clearly also of use here, although 
depending on the composition of the commission/advisory body, the requirement 
for point c) may be less important if all the relevant interest groups are 
represented (if only, as in the case of non-human species, by proxy). 
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3.4  Use of the ethical matrix in exercises in public participation 
 
EU States are now officially committed to consulting the public on the ethical 
implications of prospective novel biotechnologies, so there is an obvious need 
for effective generic tools by which these issues might be addressed. In that the 
ethical matrix was originally designed to facilitate ethical decision-making by 
people with little prior acquaintance with either biotechnology or ethical theory, 
its use in such public participatory exercises (PPE) represents both the main 
rationale for its introduction and its most formidable practical challenge. 
 In contrast with the uses described above, public participatory exercises are 
likely to be subject to a number of potentially serious limitations and constraints. 
Financial, space and time restrictions will inevitably limit the numbers of people 
who can, or wish to, participate, and there will always be questions about the 
representative nature of the groups involved, and whether, in view of time and 
motivational factors, their level of understanding of the issues is likely to result 
in meaningful conclusions. For these reasons, the following sections concentrate 
on the organizational arrangements for a typical public participatory exercise. 
Other users might also find these guidelines useful, but they will not always be 
fully applicable to their own circumstances.  
 It is assumed, for current purposes, that a workshop is to be run, under the 
auspices of a government department, to consider the ethical implications of a 
novel agri-food biotechnology; and that relevant stakeholder representatives will 
be invited to participate. Box 3 lists some basic requirements. 
 
a) An appropriately balanced group of people (e.g. stakeholders) 
willing to devote time and attention to an issue 
b) Adequate time for organizers and participants to engage in 
conscientious preparation, deliberation and reflection 
c) Access to people with expertise in the relevant fields of enquiry 
(generally including technical, sociological and economic 
experts) 
d) An environment conducive to relaxed dialogue and reflection 
e) A team of organizers who can provide constructive, unbiased 
advice 
 Box 3 Basic requirements for a public participatory exercise 
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4.  Applying the ethical matrix in workshop exercises 
 
 
The ethical matrix can be applied in a number of different forms for different 
purposes. The context in which the method is applied has a bearing on the 
timeline of the process and the resources required. There are also significant 
differences in the way a workshop is organized depending on whether a top-
down approach or bottom-up approach is used (see Section 3.1). 
 It is important to clearly define the scope of the study and the workshop 
objectives. This not only impacts on the selection of participants, but also 
influences the briefing that is sent to participants and the breadth of discussion at 
the workshop. In order to ensure that a step-by-step approach is used in the 
application of the ethical matrix methodology a generic flow diagram of the 
relevant stages is set out (see Figure 4).  
 
 
4.1  Planning phase 
 
4.1.1  Defining the scope of the study 
 
It is important to define clearly the scope of the study or stakeholder discussion. 
This includes identifying and justifying the importance or relevance of the issue, 
the aims of the study, the outcomes and the justification for using the ethical 
matrix as the methodology. 
 
4.1.2  Defining the ethical matrix 
 
The ethical matrix has evolved over a period of more than ten years and several 
different versions have been applied to different topics. It is therefore important 
to clearly define the ethical matrix that will be applied during the workshop, in 
particular stating the interest groups to be included and the specifications of the 
principles for the interest groups. 
 Which interest groups are included in the ethical matrix depends partly on 
the issue at hand. A critical factor is that 'ethical standing' is claimed for all 
interest groups specified. In other words, they are subjects of ethical 
consideration in their own right, and not just means to others' ends. For some 
interest groups, individuals are generally considered to have ethical standing 
(e.g. in the cases of people and farm animals), but in other cases only collectives 
(such as species, herds or forests) are assigned ethical standing. 
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FINAL ANALYSIS AND REPORT 
FEEDBACK TO PARTICIPANTS 
* Send draft of the workshop data analysis back to participants to allow them 
to check and review the representation of their input 
ANALYSIS OF THE DATA BY FACILITATOR 
* Qualitative analysis of the discussion 
* Quantitative analysis of data 
* Qualitative analysis of the feedback forms 
* Report on findings 
WORKSHOP 
* Opening session that defines the methodology, sets out the aims of the meeting, clarifies the context of 
the discussions and clarifies the reporting process for the presenting the results of the meeting. 
* Balanced presentation of experts' views 
* Work through the cells of the matrix in a series of discussion sessions 
* Conclude with an overview session that draws out participants' overview of the issues 
* Completion of the feedback forms 
PARTICIPANT INVITATION 
* Clarify the terms of reference for the workshop 
* Clarify the reporting procedure and the role of each participant 
* Send out participant documents including a description of  
the method and topic briefing paper 
SELECT WORKSHOP PARTICIPANTS 
* Define the relevant Stakeholders 
* Determine the relevant areas of expertise 
* Ensure that there is a diversity of opinion and interests 
represented 
FEEDBACK FORMS 
* Prepare meeting feedback forms to review process and the 
methodology 
* Prepare SWOT analysis forms for assessing the 
methodology 
WORKSHOP MATERIALS 
* Prepare an introductory presentation 
* Define the meeting sessions 
* Define the role of the facilitator 
* Prepare a briefing paper on the key ethical issues 
WORKSHOP OBJECTIVES 
* Define the aim of the workshop 
* Define the scope of the discussion 
* Define the outcomes expected from the workshop
DEFINE THE ETHICAL MATRIX 
* Define the relevant interest groups 
* Define the specifications of principles for each of the cells 
DEFINE SUBJECT AREA 
* Consideration of the technological claims 
* Consideration of key ethical issues associated with 
implementing the technology 
Figure 4  Summary of a generic protocol of the ethical matrix 
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4.1.3  Workshop objectives 
 
t is important to clearly define the workshop objectives. This not only impacts on 
the selection of participants, but also influences the briefing that is sent to 
participants and the breadth of discussion at the workshop. Objectives should 
include: 
- consideration of the technological claims; 
- consideration of key ethical issues associated with implementing the 
technology; 
- definition of the aim of the workshop; 
- definition of the scope of the discussion; 
- definition of outcomes expected from the workshop. 
 
4.1.4  Selecting the approach: top-down approach or bottom-up approach 
 
Early on in the planning process, a decision needs to be made on whether a 
primarily top-down approach or a primarily bottom-up approach will be adopted. 
The top-down approach is less flexible in terms of the structure of the ethical 
matrix, but it allows participants to interpret principles in individualistic ways, 
and to record these as additional information or as qualifications. A bottom-up 
approach is more responsive to participants' opinions, but requires a much more 
extensive initial discussion to define the structure and content of the ethical 
matrix. Consequently, by comparison with a top-down approach, time and 
resource constraints may restrict the extent to which this is a feasible approach. 
Application of the ethical matrix by a top-down approach, Diagram 1 
summarizes the separate stages of the procedure. 
 
4.1.5 Selecting the participants 
 
Defining the selection criteria is arguably one of the most significant issues 
when constructing a participant list. The list is likely to be substantially different 
if: a) an assessment of ground-roots opinion is sought (from volunteers with no 
or low public profile), rather than b) an assessment from well-known proponents 
or opponents of the technology, whose position has been previously well 
advertised. The latter may feel less free to act in an open-minded way, but their 
opinions may attract more public interest. 
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CUSTOMIZATION OF THE ETHICAL MATRIX 
• Definition of the relevant interest groups, and specification of the principles for each interest group 
WORKSHOP OBJECTIVES 
• Definition of the aim of the workshop; definition of the scope of the discussion; 
definition of outcomes expected from the workshop 
PARTICIPANT INVITATION 
• Dispatch of invitations to potential participants, together with briefing papers, summaries of the 
procedure to be used and expected outcomes 
WORKSHOP 
• Opening session: defining the methodology, setting out the aims, clarifying the context of the discussions 
and explaining the reporting process for presenting the workshop results 
• Distribution of feedback and SWOT forms 
• Balanced presentation of experts' views: questioning of experts 
• Participants' completion of the EM cells in a series of discussion sessions 
• Opportunities to review assessments following further discussions 
• Completion of the feedback forms 
ANALYSIS OF THE DATA  
• Quantitative analysis of EM data  
• Qualitative analysis of discussions and of the feedback forms 
• Report on findings 
FEEDBACK TO PARTICIPANTS 
• Dispatch of draft report of the workshop data analysis to participants to allow checking and review the 
representation of their input 
SELECTION OF WORKSHOP PARTICIPANTS 
• Identification of relevant stakeholders 
• Identification of relevant areas of expertise 
• Confirmation that a diversity of opinions and interests is represented 
WORKSHOP MATERIALS/FEEDBACK FORMS 
• Workshop aims and general introduction to the ethical matrix methodology 
• Meeting feedback forms to review process and the methodology and SWOT analysis forms for assessing the 
methodology 
• Briefing paper on the key ethical and scientific issues 
FINAL ANALYSIS AND REPORT
DEFINITION OF THE SUBJECT AREA  
• Consideration of the technological claims and of key ethical issues associated 
with implementing the technology 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 1 The ethical matrix by a top-down approach 
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 WORKSHOP 
• Opening session: defining the methodology, setting out the aims, clarifying the context of the discussions and
explaining the reporting process for presenting the workshop results  
• Discussion of the ways in which the principles are to be appropriately specified for each interest group, leading
to a consensus among participants 
• Distribution of feedback and SWOT forms 
• Balanced presentation of experts' views: questioning of experts 
• Participants' completion of the EM cells in a series of discussion sessions 
• Opportunities to review assessments following further discussions 
• Completion of the feedback forms 
ANALYSIS OF THE DATA 
• Quantitative analysis of EM data  
• Qualitative analysis of discussions and of the feedback forms 
• Report on findings
FEEDBACK TO PARTICIPANTS 
• Dispatch of draft report of the workshop data analysis to participants to allow checking 
and review the representation of their input 
DEFINITION OF THE SUBJECT AREA 
• Consideration of the technological claims and of key ethical issues associated with 
implementing the technology 
CUSTOMIZATION OF THE ETHICAL MATRIX 
• Definition of the relevant interest groups and specification of the principles for each interest group 
WORKSHOP OBJECTIVES 
• Definition of the aim of the workshop; definition of the scope of the discussion; definition of outcomes 
expected from the workshop 
PARTICIPANT INVITATION 
• Dispatch of invitations to potential participants, with briefing papers, summaries of the 
procedure and expected outcomes 
SELECTION OF WORKSHOP PARTICIPANTS 
• Identification of relevant stakeholders 
• Identification of relevant areas of expertise 
• Confirmation that a diversity of opinions and interests is represented 
WORKSHOP MATERIALS/FEEDBACK FORMS 
• Workshop aims and general introduction to the ethical matrix methodology 
• Meeting feedback forms to review process and the methodology and SWOT analysis forms for assessing the 
methodology 
• Briefing paper on the key ethical and scientific issues 
FINAL ANALYSIS AND REPORT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 2 The ethical matrix by a bottom-up approach 
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The range of participants selected ought ideally to reflect the breadth of issues 
e.g. appropriate expertise and viewpoints. As the methodology can be used with 
lay participants (e.g. members of the public) or with expert groups, the selection 
of participants should be determined by the aim of the workshop and what issues 
the research team wishes to explore or define. If appropriate (i.e. with an expert 
workshop), it may be advantageous if the known positions/starting points of the 
participants range from strongly favourable to strongly opposed to the issue.  
 Subject matter will have a strong influence over the selection of 
participants in that representatives of all stakeholder groups should be present 
(including those who represent, by proxy, interest groups such as farm animals 
and wildlife). However, the inclusion of non-experts ('men and women in the 
street') may also be considered important, even though it may slow down the 
process if 'learning curves' are steep. 
 Under certain circumstances, participants' anonymity should be preserved. 
Their particular institutional affiliations should not be identified unless 
previously explicitly agreed and an informative description should be agreed in 
advance to establish credibility.  
 
4.1.6  Workshop materials 
 
All participants should be sent appropriate briefing documents at least 2 weeks 
in advance of the meeting. These documents are produced and distributed to 
ensure that all participants can familiarise themselves with the methodology 
before the meeting. The participant invitation and briefing documents should 
include the following: 
- workshop aims; 
- general introduction, e.g. impacts of the biotechnological innovation; 
- need for participatory tools; 
- ethical matrix methodology (see Diagrams 1 and 2 for top-down or bottom-
up approach); 
- role of bioethical analysis in relation to the aim of the workshop. 
 
 
4.2  Running the workshop 
 
4.2.1  Introductory presentation 
 
In order to the set the scene for the discussion and further clarify the use of the 
ethical matrix, an introductory presentation should be given by the principal 
facilitator(s). Speaker(s) or facilitator(s) should present the following elements: 
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- opening session: 
 - definition of the methodology; 
 - introduction to the ethical matrix; 
 - setting out of the aims; 
 - clarification of the context of the discussions; 
 - balanced presentation of experts' views, and questioning of experts 
(where appropriate). 
- application of ethical matrix to a specific biotechnology: 
 - introduction to the technology or subject area; 
 - evidence used in the bioethical analysis; 
 - overall assessment and general comments; 
 - summary discussion. 
 
The facilitator should finally clarify the reporting process for the workshop and 
assure participants that their identities will remain anonymous (if that is the 
agreed condition of the workshop). 
 
4.2.2  Ethical analysis 
 
Following the opening introduction from the facilitator the participants then 
discuss the impact of the use or application of the method or technology on the 
interest groups. This is conducted in a series of discussion sessions. 
 
An important decision concerns the point at which weights are assigned to 
the separate cells of the ethical matrix. Some people who have used the 
ethical matrix consider that it is helpful to assign weights in advance of the 
consideration of any impacts, e.g. animal welfare might be considered 
'quite important' or 'very important.' Other users consider that all decisions 
about weighing are best left until the ethical evaluation stage. Indeed, there 
seems to be no intrinsic reason why this choice should not be left open. 
 Box 4 Weighing the principles 
 
In terms of the method, the ethical matrix facilitates the assessment of the 
impacts of a defined biotechnology in terms of respect (or lack of respect) for the 
ethical principles - e.g. wellbeing, autonomy and fairness as applied to the 
defined interest groups. Application of the principles aims to ensure a coherent 
approach to analysing ethical issues, which is designed to facilitate and promote 
informed decision-making. Participants' analyses of the ethical impact of the 
chosen biotechnology are facilitated by: 
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Asking them to either: 
a. discuss each of the cells of the matrix; 
b. if a more qualitative approach is needed participants are asked to complete a 
questionnaire in the form of a workbook in which are listed questions 
relevant to the principles and interest groups in the ethical matrix. Ideally, 
an audiorecording of discussions will be made, but alternatively notes may 
be taken by an experienced notetaker who is assigned solely to this task. 
 
For both of the approaches above (a and b), questions may be proposed by 
facilitators to expedite the process, particularly if time is limited. If workbooks 
are used participants may then modify these questions. If only discussion 
sessions are used, participants can then reflect on and review their early 
responses.  
 When a computational approach is used, participants are asked to attribute a 
weight to each of the impacts for each interest group in each cell of the ethical 
matrix, by determining whether the ethical principle is respected or infringed, 
using a Likert scale of: strongly infringe/infringe/neutral/respect/strongly 
respect/don't know. (This scale can been translated into numerals, where strongly 
infringe = -2 and strongly respect = +2, etc for data analysis). 
 When the scoring is completed the participants are asked to judge the 
ethical acceptability of the biotechnology by taking all their scores into 
consideration. This gives an overall ethical judgement, but it should be noted 
that this judgement is not an aggregate of the scores. 
 
 
4.3  Post workshop feedback 
 
4.3.1  Feedback forms 
 
In order to ensure the collection of views at several levels during the meeting, a 
series of feedback forms should be prepared and distributed at the end of the 
discussions. These forms: 
- record the participants' overall judgement on the technology considered; 
- allow participants to feedback their views anonymously on the topic being 
 discussed; 
- comment on the methodology and engagement process, and the overall aim 
of the workshop. 
 
Overall final judgement on the biotechnology or topic being discussed. This 
form allows participants to set out a considered opinion on the technology or 
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topic. For example if the group is discussing the possible licensing of a 
technology, categories specified on the feedback form might be: 
- qualified approval (stating the nature of the qualifications); 
- qualified rejection (stating the nature of the qualifications); 
- firm rejection; 
- don't know. 
 
An evaluation form of the methodology to include: 
- overall view of the method; 
- opinion on whether the ethical matrix aided or hindered the process; 
- suggested improvements; 
- additional comments. 
 
4.3.2  SWOT analysis 
 
An analysis of the strengths and weaknesses of, opportunities for, and threats to 
the methodology (a SWOT analysis) may be conducted. Forms of a standard 
design for such purposes should be used. This is a useful tool for further 
development of the methodology.  
 
4.3.3  Anonymity 
 
The workshop convenors should decide which of the above forms should be 
anonymous. However, the status of the form should be clearly stated on the 
feedback form. It is useful to assign each participant a code. 
 
4.3.4  Evaluating the outcomes of the process 
 
This process is performed by the organisers/facilitators. During the post-
workshop analysis, the discussion sessions are transcribed and the feedback 
forms processed. A detailed analysis is then conducted on the transcript to draw 
out the key discussion points and issues. The dialogue is analysed to examine a 
number of key points, such as areas of consensus and divergence in the group's 
and individual views.  
 
4.3.5  Reporting 
 
In order to ensure that participants are confident in the way the discussion has 
been represented and with the quality of the analysis and reporting, transcripts of 
the discussion should be sent to the participants by post. Each participant should 
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also be sent a copy of the draft report so that they can identify how their input or 
comments have been used. This process of verification allows participants to 
ensure that their comments have not been taken out of context. It can also be 
valuable to obtain expert verification of the draft report in the form of peer-
review. 
 The final report should be sent to the commissioning authority, all 
participants and relevant interest groups.  
 
4.3.6  Timeline 
 
Time Task Comments/Content 
3 months before Selection of workshop 
participants/speakers 
Can be time consuming process 
identifying suitable participants/experts 
2 months before Dispatch of invitations to 
potential participants and 
expert speakers where 
appropriate 
This allows time after the initial 
invitations are sent out to follow up on 
non-respondents and to find alternative 
participants for those who are unable to 
attend due to previous commitments. 
6 weeks before  Preparation of participant 
documents 
Description of the ethical matrix 
methodology; topic briefing paper; 
agenda for meeting 
5 weeks before  Send out participant 
documents 
 
 
4 weeks before Hire venue and book hotel 
accommodation where 
necessary 
 
3 weeks before Prepare meeting feedback 
forms to review process and 
the methodology 
Prepare SWOT analysis forms for 
assessing the methodology 
Prepare workbooks where used 
1 week before Confirm hotel accommodation 
and refreshments 
 
1 week before  Prepare introductory 
presentation 
 
 
1- 2 days Running of workshop itself  
2 weeks after Analysis of data and report on 
findings  
Circulate to participants for comments 
1 month after Final analysis and report after 
feedback from participants 
 
 
The timeline for applying the ethical matrix is highly dependent on the objective 
of the exercise and the desired outcomes. This can be very specific to the use of 
the ethical matrix and therefore should be considered on a case-by-case basis. 
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But as a guide, when running a participatory workshop a lead-time of 3 months 
is advised. 
 
4.3.7  Sample budget  
 
As with the issue of a timeline for the application of the ethical matrix, the 
resource requirements for applying the ethical matrix are very context 
dependent. The required resources very much depend on the objective of the 
exercise, the number of participants, the reporting requirements and the 
outcomes of the event. Budgetary costs may vary considerably depending e.g. on 
whether: 
- the meeting is held in-house, or whether an external venue has to be hired; 
- it is a one-day or longer meeting: (in the latter case accommodation and 
meal costs will have to be covered as well as travel expenses); 
- external speakers are used. 
 
As a simple example of the potential resources usage (sample budget), the 
following can be used a guideline for conducting an expert ethical matrix 
exercise, viz. a one-day event with 15 participants. It is assumed that the report 
will be submitted to a relevant commissioning body (e.g. government 
department, funding organisation): 
- personnel: 
 - project manager (planning the exercise, writing briefing papers, 
facilitating the meeting, writing the feedback report); 
 - project secretary (managing the participant invitations, meeting 
arrangements, meeting feedback forms, transcribing the meeting 
discussion sections); 
 - expert speakers (when invited). 
- communications: 
 - distribution of material to participants; 
 - printing of draft and final reports; 
 - press release. 
- participation: 
 - travel and subsistence payments for participants (substantial 
component of the budget). 
- facilities: 
 - hire of meeting room; 
 - AV and recording equipment. 
- other Resources: 
 - web-based or email-based questionnaire and report forms. 
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4.4  Strengths and limitations of the method 
 
A number of strengths and limitations of the ethical matrix have been raised and 
discussed in previous sections. The following list of strengths and weaknesses 
anonymously recorded from workshop participants may aid users to think 
through a number of logistical and methodological issues: 
- strengths: 
 - identifies issue and focuses debate; 
 - very good vehicle for education/discussion; 
 - teases out issues and peoples' feelings; 
 - enables a wide range of issues to be discussed; 
 - aids the decision-making process; 
 - a fruitful way of organising an ethical debate; 
 - allows diverse groups to come together; 
 - considers factors that might otherwise have been ignored; 
 - provides structure for discussion; 
 - allows most key issues to be considered; 
 - (allows one) to learn and consider ideas and perspectives of others; 
 - (provides a) positive/constructive environment for developing 
discussions; 
 - allows a broad range of expertise to have a formative discussion; 
 - forces the formation of an argument; 
 - encourages examination of issues from a wide variety of stakeholder 
perspectives; 
 - gives opportunity for everyone to express views and share ideas; 
 - (encourages) open-mindedness - and so a better appreciation of some 
issues. 
- limitations: 
 - devotes equal time to subjects which vary in importance; 
 - some pertinent issues could be missed; 
 - very vocal participants may override others; 
 - how do we get to a decision point?; 
 - composition of the group may influence the main points of emphasis; 
 - may restrict analysis from different philosophical basis; 
 - isolates topic from wider more general issues and trends; 
 - difficulty in getting into depth on each topic; 
 - lack of time/participants' expertise will lead to incorrect ill-considered 
  conclusions. 
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5.  Case studies 
 
 
The ethical matrix has been used in a number of academic and educational 
projects. The Biotechnology and Biological Sciences Research Council 
(BBSRC) in the UK funded a project 'Bioethical analysis in technology 
assessment: Application to the use of bovine somatotrophin and automated 
milking systems' (1997 - 2000) in which the ethical matrix was used to assess the 
potential impacts of two dairy biotechnologies. The BBSRC (2001) also 
financed a one-year study into public and stakeholders' views of issues arising 
from the potential use of biological systems such as microorganisms and plants 
to decontaminate polluted land, water and air in the UK. This was part of a wider 
study examining how interested parties may be enabled to identify and discuss 
issues arising from new biotechnologies such as bioremediation, using the 
ethical matrix. 
 A Norwegian group used the ethical matrix during a two-day workshop 
with stakeholders on the future of the Norwegian fishing industry (1999), funded 
by the Research Council of Norway. In 2004, the same group used another 
variant of the ethical matrix to assess the ethical aspects of genetically modified 
salmon to support a pending decision of the Ethical Council on Patent Issues, 
funded by the EU project Ethical Bio-TA Tools.  
 The University of Nottingham Research Committee (2001) funded the 
development of an interactive computer model of the ethical matrix. The UK 
animal welfare organization, Compassion in World Farming (CIWF, 2002 - 
2003) commissioned a study on 'Ethics and animal farming: Using the ethical 
matrix to make ethical decisions about animal farming' (www.ethicalmatrix.net), 
the purpose of which was to design and develop a teachers' pack. An important 
component of this was an interactive web site based on the ethical matrix, for use 
as a teaching aid for 16-20 year olds in schools and colleges. The web-based 
exercise provides simplified ethical theory and applies the ethical matrix to test 
cases e.g. broiler chicken production, pig production and salmon farming.  
 This section illustrates the use of the ethical matrix by summarizing is 
employment in the ethical analysis of a number of agri-food biotechnologies. 
The collective experience of these applications may provide useful background 
information for those wishing to use the ethical matrix to address new issues. 
 The following cases have been chosen for discussion, but other experiences 
with this method can be reviewed in the reference section: 
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- bovine somatotrophin (bST) use in dairy production systems; 
- GM organisms in bioremediation; 
- GM salmon. 
 
 
5.1  The case of bovine somatotrophin (bST) 
 
This example involves a hormone called bovine somatotrophin (bST), which 
increases milk yield when injected subcutaneous into dairy cattle. The hormone, 
which is produced by recombinant DNA technology (genetic engineering) in 
cultures of the bacterium E. coli, was the first GM product to be used (in the 
USA) in animal agriculture.  
 By injecting cows every two weeks with bST, farmers can expect an 
average increase in yields of 12-15%; and, although slight changes in nutrient 
content may result, the overall concentrations of nutrients in bulked milk are 
probably unaffected. However, because higher metabolic demands may lead to 
increased rates of illness, there is a risk that the welfare of injected cattle will be 
diminished. The treatment also leads to an increase in the milk concentration of 
insulin-like growth factor 1 (IGF-1), which is a potent mitogen (i.e. it stimulates 
cell division). If the increased milk concentration of IGF-1 was physiologically 
significant and if it were to remain biologically active at the level of the gut 
mucosa (a claim which is contested by some scientists), it might pose a public 
health threat to people consuming the milk or dairy products.  
 Figure 2 shows how the use of an ethical matrix can help to summarise the 
ethical issues raised by this technology in a systematic way that is based on the 
principles that comprise the common morality. Box 5 describes in more detail 
the ways in which the different principles are specified for each of the four 
identified interest groups. These formulations of the ethical principles in the 
ethical matrix have been used in workshops conforming to the top-down 
approach described in Section 4.1.  
 
5.1.1  Ethical evaluation of bST use 
 
Box 6 summarises the lines of evidence (see Section 2.1) that have been 
presented for the different cells of the ethical matrix applied to bST (Note: In the 
USA, bST was licensed for commercial use in 1994. In contrast, in the EU in 
1999, an earlier moratorium on its use was extended indefinitely). According to 
different interpretations of the importance to be attached to this evidence, the 
governments of the USA and the EU reached opposing decisions on the 
acceptability of licensing bST for commercial use. Although in neither case were 
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the decisions expressed in terms of ethical acceptability, it is clear that each 
would be justified, if it was requested of their supporters, in ethical terms: hardly 
anybody admits to acting unethically. 
 
Dairy farmers 
Wellbeing: satisfactory incomes and working conditions for farmers and farm workers: 
('satisfactory' is obviously debatable, but it is a better word than 'adequate', which might 
imply 'just enough to meet bare necessities') 
Autonomy: allowing farmers to use their skills and judgement in making managerial 
decisions, e.g. in choosing a farming system 
Fairness: farmers and farm workers receiving a fair price for their work and produce, and 
being treated fairly by trade laws and practices 
 
Consumers  
Wellbeing: protection from food poisoning (and harmful agents e.g. residues of veterinary 
drugs); this also refers to the quality of life citizens enjoy as a consequence of a 
productive and profitable farming industry 
Autonomy: a good choice of foods, which are appropriately labelled, together with 
adequate knowledge to make wise food choices; this principle also encompasses the 
citizen's democratic choice of how agriculture should be practised 
Fairness: an adequate supply of affordable food for all, ensuring that no one goes hungry 
of poverty 
 
Dairy cows 
Wellbeing: prevention of animal suffering; improving animal health; avoiding risks to 
animal welfare 
Autonomy: ability to express normal patterns of instinctive behaviour, e.g. grazing and 
mating 
Fairness: treated with respect for their intrinsic value as sentient beings rather than just as 
useful possessions (instrumentally) 
 
The Biota 
Wellbeing: protection of wildlife from harm (e.g. by pollution), with remedial measures 
taken when harm has been caused 
Autonomy: protection of biodiversity and preservation of threatened species (and rare 
breeds) 
Fairness: ensuring sustainability of life-supporting systems (e.g. soil and water) by 
responsible use of non-renewable (e.g. fossil fuels) and renewable (e.g. wood) resources; 
cutting greenhouse gas emissions 
Box 5 A more detailed specification of the principles in an ethical matrix for bST use (See 
Figure 2) 
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Dairy farmers  
Wellbeing: Some USA farmers using bST have increased their profits but economic data 
suggest other farmers use it at a loss. 
Autonomy: Farmers in the USA have an opportunity to increase productivity, but some 
might feel economically obliged to use bST (exemplifying the so-called 'technological 
treadmill'). 
Fairness: Farmers in the USA are given the option of using a productivity-boosting 
technology. Farmers avoiding bST can label milk accordingly, but only at their own 
expense. 
 
Consumers 
Wellbeing: An EU report by public health experts suggested possible (but currently poorly 
defined) risks of consuming IGF-1 (whose concentration increases in milk of treated 
cows). An FAO/WHO committee denied any significant health risk. 
Autonomy: In the USA most milk is unlabeled, denying consumers a choice on whether to 
purchase milk from treated cows.  
Fairness:There appears to be no clear evidence of an impact on milk prices. 
 
Dairy cows 
Wellbeing: Cattle suffer increased disease rates (such as mastitis, lameness, metabolic and 
digestive disorders), as noted on the bST product label, which lists 21 possible adverse 
side effects. The EU banned bST largely on animal welfare grounds, but the 
manufacturers claim the diseases are treatable by medication (e.g. antibiotics for mastitis).
Autonomy: Behaviour may be adversely affected by lameness, by reduced grazing 
opportunities due to increased concentrate feeding, and by decreased fertility. 
Fairness: Some people claim that the excessively instrumental use of cows is an 
infringement of their intrinsic value. Others claim that the technology accords with 
accepted social norms.  
 
Biota 
As quantitative data are lacking, claims are largely speculative. 
Claimed positive features of bST use are that reduced cow numbers (because fewer cows 
are needed to produce the required milk yield) will lead to less environmental pollution 
(e.g. fertilizer use for forage growth and reduced silage run off) and lower greenhouse gas 
emissions (methane is exhaled by ruminants). 
Claimed negative features of bST use are that mergers in the dairy industry (as non-user 
farmers leave the industry), resulting in fewer but much larger dairy farms, will increase 
point-source pollution (e.g. excess fertilizer use, silage run off) and jeopardize 
biodiversity and sustainability by reliance on fossil fuels for fertilizer production etc and 
routine veterinary medication. 
Box 6 A brief analysis of bST use in dairying with reference to Figure 2/Box 5 
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We can thus summarise the two positions, according to the ethical criteria that 
have been defined: 
- the ethical acceptability of bST use for those who have licensed it (e.g. the 
USA) would probably cite the need to respect farmers' freedom to innovate; 
and the economic benefits to the manufacturers of bST, to the economies of 
countries producing it, to the farmers using it, and, were prices to fall, to 
consumers of dairy products. Moreover, if its use led to reduced cow 
numbers it might result in marginally reduced emissions of methane. This 
case also rests on perceptions that the welfare of treated cows is not affected 
significantly (or that increased disease can be effectively treated) and that 
there are no risks to human safety, so that labelling is unnecessary. Job 
losses in the dairy industry would not be seen as an ethical issue, being 
merely a feature of market economies, in which competition guarantees 
efficient production; 
- the ethical case of those who have banned bST use (e.g. the EU) would 
probably focus on respects in which it appears to infringe commonly 
accepted ethical principles. They would point to authoritative reports 
suggesting that bST use substantially increases the risk of pain and disease 
in dairy cows, and that it might present a risk to human safety through 
ingestion of increased IGF-1 in milk. Moreover, they might consider that 
bST use would reduce farmers' autonomy; undermine consumer choice if 
milk products from treated cattle were not labelled; jeopardise public health 
if rejection of dairy products followed the licensing of bST (because milk is 
a valuable source of dietary nutrients); and increase local pollution through 
the intensification of dairying. 
 
The above description provides a guide to people wishing to identify issues 
relevant to reaching a judgement on bioethical concerns. But employing a 
suitable tool for ethical analysis does not guarantee a genuine ethical evaluation. 
If users adopt a partisan position on the issue, e.g. allowing bias to influence the 
choice of scientific data, then the tool is unlikely to prove of value. 
 A conceptual device to counter this tendency is to try put yourself in the 
shoes of each interest group in turn as the different cells specifying its interests 
are considered. In essence, it amounts to recognising that ethics is concerned 
with caring about other beings with ethical standing that are described in the 
ethical matrix. It has been claimed that 'ethics in its full scope aims at care of the 
other', and while only certain occupations are conventionally classed as 'caring 
professions' it is implicit in the remit of ethics that care should be exercised in 
relation to others (necessarily, but not exclusively, people). If someone were not 
prepared to admit to caring about anyone or anything other than him- or herself, 
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it would be impossible for them to use the ethical matrix. But even if they 
expressed concerns for only one other cell of the ethical matrix, say, respect for 
farmers' profits or, alternatively, respect for animal welfare, that revelation 
would starkly expose the value system determining their choices. In fact, 
experience shows that most people do ascribe some value to all cells of the 
ethical matrix, although the degree of value ascribed varies both with the 
individual and with the issue being discussed. 
 Putting yourself in the shoes of others (developing 'an imaginative 
conception of others' predicaments') may not be easy, especially when the 
interest group concerned is non-human (although there is increasing scientific 
evidence e.g., on the welfare of farmed animals, to add substance to our 
imaginative conceptions). But it is arguable that genuine ethical insight depends 
on conscientious attempts to empathise in this way. 
The relative importance of the impacts recorded for each of the cells is 
ideally only revealed at the evaluation stage, when the separate impacts are 
weighed. This step involves the attempt to seek the proper balance between the 
right and the good, and between intellect and intuition. In the words of 
philosopher Nagel, 'The capacity to view the world simultaneously from the 
point of view of one's relations to others, from the point of view of one's life 
extended through time, (and) from the point of view of everyone at once ... is 
one of the marks of humanity'. 
 
 
5.2  The case of using GM organisms in bioremediation 
 
This case focuses on the use of bioremediation technologies. This one-year study 
was commissioned by the Biotechnology and Biological Sciences Research 
Council (BBSRC) as part of their on-going stakeholder engagement work 
(www.bbsrc.ac.uk). 
 Bioremediation is a collective term used to describe the use of micro-
organisms and/or plants to detect, degrade or remove environmental pollutants 
from soil, water or air. Decades of industrial and waste disposal activities have 
left the UK (and many countries in Europe) with a significant contaminated land 
problem, affecting as much as 360,000 ha (1.3% of the UK land area). In 2002, 
this contamination was believed to be distributed over as many as 100,000 sites, 
with a predicted clean-up cost of over £15 billion. The preferred remediation 
approach is to send contaminated material to landfill sites for disposal. However, 
this method is increasingly viewed as an unsustainable option. Bioremediation, 
used on less than 5% of sites in 2002, is promoted as a possible sustainable and 
cost effective method for dealing with a variety of environmental pollutants.  
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 The study focused on emerging bioremediation technologies being 
developed from recent advances in plant and bacterial genomics, as a case study 
to map potential social and ethical issues. The work explored the use of the 
ethical matrix and its value in aiding the management of issues raised by GM 
bioremediation technology development. Ways of facilitating dialogue and 
identifying issues and potential concerns raised by these emerging 
biotechnologies were also explored by using the ethical matrix. The ethical 
matrix set out below was used by participants to explore the key issues: 
 
Respect for: Wellbeing Autonomy Justice 
Users Efficacy, safety 
and 
remuneration 
Freedom to adopt 
or not adopt 
Fair treatment in 
trade and law 
Affected 
citizens 
Safety and 
quality of life 
Democratic 
decision-making 
Individual and 
regional justice 
Technology 
providers 
Commercial 
viability 
and working 
conditions 
Ability to innovate Equitable trading 
(market) system 
Environment Protection of the 
environment 
Biodiversity of 
biotic populations 
Sustainability of 
the 
environment 
 Figure 5 An ethical matrix used in the ethical analysis of bioremediation 
 
5.2.1  Methodology 
 
Five focus groups and a final workshop (n=12) were conducted during the study, 
with an NGO group (n=5), a national women's organisation (NCW group; n=7), 
a technology/regulator group (technology group; n=11) and two general public 
groups (n=8 for both). The ethical matrix was used by each group to map the 
potential impacts (positive and negative) of these technologies for various 
interest groups. Participants considered whether the application of the 
technology might infringe or respect the principles as applied to each of the 
interest groups. Participants were also asked to examine the types of formal and 
informal policies that might enhance respect for the ethical principles for the 
chosen interest groups (e.g. enhance respect for citizens' autonomy by improving 
local community dialogue). 
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5.2.2  Findings from the consultation  
 
In terms of findings from the study, the majority of participants demonstrated a 
very precautionary approach to the use of GMOs for bioremediation. The 
importance of demonstrating a clear need for GMO use was discussed in the 
focus groups, particularly the industry group, and the workshop. As a result of 
the UK GMO crop trial reviews, the characterisation of risks (safety and 
societal) and the perceived alternative research trajectories (e.g. [i] improved 
classification and use of non-GM organisms and [ii] improved conventional 
plant breeding strategies) participants perceived only a limited requirement for 
GMO bioremediation applications for specific persistent pollutants. 
 All focus group participants were asked to evaluate the ethical matrix as a 
participatory tool and clarify their judgements by means of a SWOT analysis. 
Over 85% felt the ethical matrix positively aided the discussions, with other 
participants expressing a neutral view on its use. The ethical matrix clarified the 
issues, both conflicts and concords, in order to allow policy-makers a greater 
confidence in their decision-making and to facilitate defensible biotechnology 
assessment procedures. Rather than being seen as restrictive, feedback indicated 
that the framework was well received by the study participants. All participants 
who commented also felt that it was important that research bodies and funders 
are involved in broad stakeholder engagement programmes. A number of 
participants commented on the need to initiate early engagement programmes in 
order to maintain confidence in the research funding strategies and research 
management. 
 
AFFECTED CITIZENS ENVIRONMENT 
• Once a contaminated site has been 
designated, concerns expressed about the 
time it could take to remove the 
contamination if bioremediation was used 
instead of landfill. Concerns were also 
raised regarding the safety of the site 
during this process (Public B) 
• The significance of the health risk from 
the contaminated site was seen to be the 
most important factor in site neighbours' 
acceptance of any time delay with 
bioremediation (Public B) 
 
 
 
 
• Concerns expressed regarding 
potential impacts from the effects of 
metabolites or by-products from the 
introduction of microbes (NGO) 
• Concerns expressed regarding 
potential impacts on ground water 
quality and air pollution from 
bioremediation techniques (NGO) 
• Concerns expressed regarding 
potential impacts on wildlife from 
phytoremediation (e.g. poisoning, bio-
accumulation) (NGO; NCW) 
 
 
 
 
 38
• When building houses on bioremediated 
sites, concerns were raised that not all the 
contamination may be 'removed' (Public 
A and B). Concerns expressed regarding 
impacts on vulnerable groups (e.g. 
children) and possible risks from growing 
fruit and vegetables (Public A) 
• Bioremediation technologies, 
particularly in-situ technologies, may 
reduce transport aggravation factors 
(Industry) 
• With phytoremediation, concerns were 
raised about contaminates 'getting back' 
into the food chain (NGO; Public A) 
• Where there is scientific uncertainty, it is 
important that a comprehensive risk 
assessment is conducted which is then 
available to interested parties (NCW) 
• Need to be able to demonstrate that this is 
a safe solution for cleaning up 
contaminated land particularly if the land 
will be used for new houses (Public B) 
• When dealing with a contaminated site 
there needs to be a system of decision-
making where local communities have a 
real input into the process so that the 
most appropriate method for all 
interested parties can be applied (NGO) 
• Biological processes were characterised 
as being unpredictable. Questions raised 
about who would be liable if a long-term 
problem arose due to the use of 
bioremediation techniques, particularly 
for land subsequently used for leisure 
purposes or housing (NGO, NCW) 
• In order to ensure confidence in 
bioremediation techniques long-term 
monitoring and adequate application of 
current legislation will be extremely 
important (NCW)  
 
• Concerns expressed regarding 
potential impacts on soil microbial 
ecology from the introduction of 
microbes (NGO) 
• Concerns raised about the use of non-
indigenous organisms and impacts on 
soil microbial ecology (NGO) 
• Concerns raised over the lack of 
microbial knowledge particularly in 
relation to soil ecology, and the 
possible environmental impact from 
the use of microbes (e.g. in 
bioaugmentation) (NGO; Public A) 
• Concerns expressed regarding the use 
of GM technologies and potential 
impacts on ecosystems, particularly 
concerns regarding unpredictability 
(e.g. gene flow) (NGO; NCW) 
• Need to ensure reliable containment 
of any GM and non-indigenous 
organisms (NCW) 
• Need to assess the environmental 
impact of GM options on a case by 
case basis (NGO; Public A; Public B; 
Industry) 
• There is a significant need to explore 
GM options to deal with more 
persistent environmental contaminants 
(Public A) 
• Bioremediation was characterised as 
being a sustainable technology if 
certain conditions were met (NGO; 
Industry; Public A; Public B; NCW) 
• The real environmental benefits 
cannot be clearly defined at present 
(Public B) 
• These biotechnologies should not be 
used to allow polluters to continue to 
pollute, on the grounds that these 
biological methods could be applied 
to clean-up contamination at a later 
stage (NGO; NCW) 
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TECHNOLOGY PROVIDERS TECHNOLOGY USERS 
• Important that providers conduct 
comprehensive studies and field trials 
should be carried out before specific 
technologies are used commercially 
(Industry) 
• At present, site liability is the 
responsibility of the contractor. This is 
hindering field scale projects especially 
for SMEs (Industry) 
• Comprehensive funding of 
demonstration projects is needed in 
order to stimulate the bioremediation 
market (Industry) 
• The use of GM organisms do not appear 
to be necessary. Indigenous organisms 
could be adequately harnessed (NGO; 
Industry) 
• GM technologies are unlikely to meet 
current risk assessment and safety 
requirements (Industry; Public A) 
• There is a need to explore/investigate the 
potential of these technologies, including 
GM options, through investment in 
research programmes, however, there are 
concerns about a number of the potential 
risks (NGO; Public A and B) 
• A number of companies are conducting 
low value remediation contracts that are 
not delivering the promised results. This 
is affecting the overall view of 
bioremediation as an effective method 
(Industry) 
• There is very little assistance (from 
central government) to help local 
authorities encourage sustainable 
remediation methods (Industry) 
• Due to the overall benefits of 
bioremediation, comprehensive 
government funding for research and 
development should be encouraged 
(Public A) 
 
 
• Bioremediation will only be effective 
and economical for particular 
contaminated sites (Industry) 
• There are opportunities for 
bioremediation to be used to treat sites 
that are currently problematical 
(Industry) 
• More information is needed on the 
efficacy of the various methods and 
detailed information is needed to 
predict its applicability in a wide 
range of situations (Industry) 
• Widespread use of bioremediation 
will depend on changes in legislation 
that will affect the economic 
advantage of landfill (Industry) 
• Concern that users will always choose 
the cheapest option. Without changes 
in legislation cost will continue to be 
the key remediation driver (NGO) 
• Landfill tax system is not effective for 
encouraging technologies such as 
bioremediation and discouraging 'dig 
and dump' (NGO) 
• Recent changes in legislation (Part 
IIA) will allow regulators to 
encourage the use of certain types of 
remediation (e.g. bioremediation) 
(Industry) 
• Timescales will always be a problem 
for bioremediation, there is a need to 
find ways to help overcome this 
barrier possibly through proactive 
legislation (Industry)  
• The application of novel 
bioremediation methods need to be 
further validated for UK sites 
(Industry) 
• Bioremediation is being applied in 
other European countries successfully, 
the UK should learn from these 
successes (Industry) 
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• Bioremediation has the potential to be a 
valuable remediation technology but it is 
at risk of not being widely applied 
because of our current poor development 
strategies (Industry) 
• Commercial bodies and local authorities 
should ensure that all bioremediation 
risk assessment data produced by 
technology providers is available to the 
public (NCW)  
• The media response to bioremediation 
will affect users' views and use of 
these techniques (Public B) 
• Any issues of uncertainty (e.g. 
biorisks) will affect users' willingness 
to use bioremediation (NGO) 
• Bioremediation could encourage a 
more combined reclamation (reuse) 
approach rather than sending to 
landfill (NGO) 
Example issues raised during the group discussions (Potential impacts for sample interest 
groups) 
 
 
5.3  The case of GM salmon  
 
Research groups in Norway have used the ethical matrix in order to explore 
ethical aspects of GM salmon, modified for growth enhancement. A bottom-up 
approach was used with lay-people. The details of the case are not discussed 
here, but a simplified ethical matrix is presented in order to illustrate: a) the 
approach and the use of principles, and b) how the use of the ethical matrix can 
clarify important ethical considerations to such an extent that proponents and 
opponents can identify how different value judgements influence the ethical 
acceptability of one major consideration. 
 This form of the ethical matrix used four prima facie principles, i.e. the 
principle of wellbeing was explicitly defined as the prima facie duty to reduce 
harm, and increase benefit. This was done to clarify the consideration of risks of 
the GM technology use against the potential benefits. Thus the initial ethical 
matrix is represented in figure 6. The participants explored how the proposed 
technology would affect the specified principles in the different cells. In Figure 7 
the negative impacts are marked with '-' and the positive impacts are marked 
with '+'. The justification for the choice of the descriptions/translations for each 
cell is not included here, as this would go beyond the purpose of this section. 
 
 
5.4  Alternative ways in which the ethical matrix may be used 
 
As noted earlier, the ethical matrix is a versatile tool for ethical assessments. 
Different groups have therefore developed variations of the ethical matrix that 
may be further adapted to either the topics under discussion or the specific socio-
political culture of deliberation. The best way to find out what suits one's 
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purposes is to start with one of the more standard versions and develop 
variations in light of one's experiences. We refer to the cited literature for further 
examples of such variations. 
 
Respect for: Increase of 
benefits 
Reduction of 
harm 
Dignity Fairness 
Fish producers Profit and work 
conditions 
Dependency on 
natural resources 
and supplies 
Freedom to choose
technology 
 Fair trade 
conditions 
Consumers Nutritional 
quality 
Safe food Consumer choice Availability 
 
Treated fish Disease 
resistance 
Animal welfare Freedom of 
movement 
Respect for telos 
(natural 
capacities) 
Environment Preservation Pollution Biological 
diversity 
Regional 
sustainability 
Figure 6 An ethical matrix used in the ethical analysis of GM Salmon 
 
Respect for: Increase of 
benefits 
Reduction of harm Dignity Fairness 
Fish 
producers 
 + quick 
harvest  
 + less use of 
expensive  
resources 
 + less strain by long 
cold periods 
 - some added costs for 
improved control 
 
 + may choose to 
 produce GM 
 salmon or not 
 + possibility to 
compete if others 
start production 
Consumers  None (assume Assumedly no risk 
 nutritional 
value 
identical?) 
 (Allergies?) 
 Depending on 
 labelling or not 
 + some reduction 
in price 
 + availability also 
in weak markets? 
Treated fish  No benefit  - animal welfare: 
some deformities?  
 - no good fish feed for
such growth? 
 - less disease 
resistance? 
 Unchanged in 
 relation to 
ordinary 
 farmed fish 
 - less ability to 
manage stress? 
 - change of 
behaviour? 
Environment  None  - potentially reducing 
 variability in wild 
 stocks 
 - more transmission of
 diseases? 
 - possibility for  
 reduced 
biodiversity 
 - cannot be 
integrated 
into natural system 
 - needs more 
separation 
Figure 7 Simplified consequence matrix for GM salmon 
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6.  Further information and resources 
 
 
This section provides potential users with additional information on the method 
and on potential training events and further contacts. 
 
 
6.1  Training 
 
In September 2005, members of the Centre for Applied Bioethics, University of 
Nottingham, UK and NENT, Norway conducted a two-day training event with 
the Lithuanian Bioethics Committee and members of Ministry of the 
Environment. A separate report of this event can be downloaded from the project 
website (www.ethicaltools.info). If you are interested in training events or 
organising a workshop please contact:  
 
Sandy Tomkins 
Centre for Applied Bioethics  
School of Biosciences 
University of Nottingham 
Sutton Bonington Campus 
Loughborough 
Leics LE12 5RD 
Tel: +44 (0) 115 951 6325 
sandy.tomkins@nottingham.ac.uk 
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6.3  Further contacts 
 
If you are interested in discussing the use of the ethical matrix please contact: 
 
Professor Ben Mepham or Dr Kate Millar 
Centre for Applied Bioethics and School of Biosciences 
University of Nottingham, Sutton Bonington Campus 
Loughborough, Leics LE12 5RD 
E-mail: Kate.Millar@nottingham.ac.uk 
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Professor Dr. Matthias Kaiser 
Director of The National Committee for Research Ethics in Science and 
Technology (NENT) 
P.O.Box 522 Sentrum, 
N-0105 Oslo 
Norway 
E-mail: matthias.kaiser@etikkom.no 
 
